Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan in Adenocarcinoma of the Esophagus and Gastric Cardia
NCT00003748Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Aug 1998
- Primary completion
- Jun 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in esophageal adenocarcinoma (EAC), Gastric cardia adenocarcinoma (GCA), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Aug 1998; status: completed.
02
Drugs
irinotecan
03
Conditions
esophageal adenocarcinoma (EAC)Gastric cardia adenocarcinoma (GCA)
Beyond the preview
Go deeper on NCT00003748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003748.